Follow
Screening
Screening is a test to detect early disease or risk factors for disease in large numbers of apparently healthy individuals. In medicine, it is checking for disease when there are no symptoms.
OCT 15, 2024 | 8:00 AM
Discover how targeting RNA-binding motif protein 39 (RBM39) is unlocking new possibilities in cancer treatment. RBM39, a key player in transcriptional regulation, alternative splicing, and p...
OCT 09, 2024 | 9:00 AM
In the fast-paced world of healthcare-associated infections (HAIs) management, time is of the essence. Traditional diagnostic techniques, which can take days to yield results, often lead to...
OCT 09, 2024 | 9:00 AM
In the fast-paced world of healthcare-associated infection (HAI) management, time is of the essence. Traditional diagnostic techniques, which can take days to yield results, often lead to ch...
On Demand
C.E. CREDITS
Engineered immune cell therapies offer the promise of more tailored interventions than traditional systemic checkpoint blockades, but so far remain ineffective across the majority of clinica...
September 19, 2024 | 10 AM EDT, 7AM PDT, 4 PM CEST
The sample throughput of high-sensitivity liquid chromatography-mass spectrometry (LC-MS) proteomics analysis is restricted by the pressure limitations of LC and column hardware, with some m...
SEP 18, 2024 | 9:00 AM
C.E. CREDITS
abstract Learning Objectives Understand how the health disparity affects ordering M-protein testing at the right time. Discuss Analytical considerations of the test panel/methods ordered Ide...
SEP 17, 2024 | 9:00 AM
Discover the latest innovations in cervical cancer prevention and molecular diagnostics. This event will showcase cutting-edge advancements in integrated molecular automation and innovative...
SEP 10, 2024 | 10:00 AM
C.E. CREDITS
The field of carrier screening has rapidly developed over the past several years, in terms of technology, guidelines for testing, and patient knowledge. This webinar aims to educate the audi...
AUG 27, 2024 | 9:00 AM
C.E. CREDITS
Join Dr. Steben and Dr. Riedel in their discussion of the HPV landscape and the shift to primary screening. Dr. Steben will set the scene with a discussion of: HPV prevention and prevalence...
JUL 17, 2024 | 12:00 PM
C.E. CREDITS
Recently, the American Association of Clinical Chemistry (AACC), now Association of Diagnostics & Laboratory Medicine (ADLM), in collaboration with the American Diabetes Association (ADA...
JUL 10, 2024 | 10:00 AM
Dr. Jim Richter and Dr. Clara Latorre will walk through the ever changing landscape of cervical screening and management. Cervical screening supports both pap cytology and HPV testing, depen...
JUN 25, 2024 | 9:00 PM
Over 95% of potential anti-cancer drugs failed in clinical trials despite vast investment to bring the drug to market. The last decade of cancer research has also seen numerous advances aime...
JUN 25, 2024 | 9:00 AM
C.E. CREDITS
Cytomegalovirus (CMV) is a ubiquitous infection and congenital CMV (cCMV) infection is the most common non-genetic cause of hearing loss in infants and children. However, most pregnant women...
JUN 04, 2024 | 11:00 AM
TBD...
JUN 04, 2024 | 10:30 AM
As one of the earliest partners and the first one in Asia-Pacific region of Berkeley Lights (now Bruker Cellular Analysis), Nona Biosciences has built a state-of-the-art single B cell clonin...
JUN 04, 2024 | 10:00 AM
Despite demonstrated efficiency in antibody generation, classical immunization strategies and subsequent hybridoma generation often face strong limitations when it comes to speed and poorly...
MAY 15, 2024 | 6:00 AM
C.E. CREDITS
The Genomes2People Research Program (G2P), led by Robert Green at Brigham and Women’s Hospital, the Broad Institute, Ariadne Labs, and Harvard Medical School, conducts research to acce...
MAY 08, 2024 | 7:00 AM
Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will di...
APR 30, 2024 | 9:00 AM
C.E. CREDITS
Nanovials are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell seq...
APR 17, 2024 | 10:30 AM
C.E. CREDITS
Cannabinoid hyperemesis syndrome (CHS) is a constellation of intractable vomiting, abdominal pain and hot bathing behavior that solely occurs in the context of heavy chronic use of THC-predo...
MAR 20, 2024 | 9:00 AM
C.E. CREDITS
Nanovials are emerging as an accessible platform for performing single-cell functional screening leveraging standard instrumentation, such as flow cytometers and microfluidic single-cell seq...